June 28, 2014
- Office of Compliance Annual Report 2018 (PDF - 979KB)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Drug Shortages
- Asparaginase Erwinia Chrysanthemi (Erwinaze) (Updated - Currently in Shortage)
- Bupropion Hydrochloride (Zyban) Tablets (New - Discontinuation)
- Carisoprodol Tablets, USP (New - Currently in Shortage)
- Clindamycin Phosphate and Benzoyl Peroxide (Duac) Topical Gel (New - Discontinuation)
- Lorazepam Injection, USP (Updated - Currently in Shortage)
- Ranitidine Injection, USP (New - Currently in Shortage)
- Ropinirole Hydrochloride Extended Release (Requip XL) Tablets (New - Discontinuation)
- Triamterene and Hydrochlorothiazide (Dyazide) Capsules (New - Discontinuation)
- Epidermolysis Bullosa: Developing Drugs for Treatment of Cutaneous Manifestations Guidance for Industry
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario